AI Medica

AI Medica (branded Aimedica) develops evidence-based electronic health record automation software aimed at physicians and healthcare executives. Its platform is organized around three named products — Aicode, Aipro and Aicalc — and targets increased reimbursement accuracy, care quality and physician compensation. The stated goal is to make value-based care contracts easier for physicians to implement by embedding evidence-based resources directly into clinical workflows.

The coding side of the platform covers both inpatient and outpatient settings. For inpatient work it emphasizes faster chart review, fewer clinical documentation improvement queries and auditable results; for outpatient work it supports evidence-based level-of-service determination and revenue capture, with the aim of avoiding both under-billing and over-billing. Automated level-of-service billing and auditing run inside the EHR itself.

A second component is clinical risk stratification. The platform surfaces a large library of validated clinical scores and calculators spanning mortality, infection, readmission, morbidity and complication risk — including CHA₂DS₂-VASc, HEART, RCRI, Caprini, PESI, MELD, CURB-65, HAS-BLED, APACHE II, qSOFA, Child-Pugh, ASCVD, SCORE2 and NEWS 2, among others — alongside laboratory and dosing calculations such as creatinine clearance, fractional excretion of sodium and urea, corrected sodium and calcium, and ideal/adjusted body weight.

Founding story

The company was founded by Adam Robison, MD, who serves as Chief Medical Officer and describes building AI Medica in response to electronic health records not being designed for clinicians, with the view that the future of medicine depends on optimizing EHRs with evidence-based resources.

Business model

The company sells its platform to healthcare provider organizations and physician groups through a direct sales motion, with website calls to action directed at contacting sales and requesting a demo.